Voyager Therapeutics, Inc.'s TRACER platform shows strong preclinical results for BBB-crossing gene therapies, securing multi-billion dollar deals with Novartis and Neurocrine, but lacks clinical ...

Nanobiotechnology for Gene Transfer Across the BBB Viral vectors have limitations for gene therapy of brain tumors by systemic administration due to the difficulty in crossing the BBB.

The vehicle stood out from the rest for its museum-like quality and its vibrant blue coloring, winning first place among ...

By Gene Nichol I have, I’ll concede, been more critical of the North Carolina Supreme Court than most. I have watched, and complained of, their lawlessness, their bold and unrelenting ...

Crossing the Cell Membrane Without Viruses May 14, 2025. By ... Their RNA Gene Writer™ platform includes an mRNA that encodes the Gene Writer protein plus a template RNA.

A study reveals that a common genetic mutation doubles the risk of dementia in men, linking it to problems with iron ...